Garland Capital Management Inc has filed its 13F form on October 30, 2024 for Q3 2024 where it was disclosed a total value porftolio of $130 Million distributed in 30 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Jpmorgan Chase & CO with a value of $7.81M, Abb Vie Inc. with a value of $7.54M, Procter & Gamble CO with a value of $6.42M, Travelers Companies, Inc. with a value of $6.25M, and Merck & Co., Inc. with a value of $6.02M.

Examining the 13F form we can see an decrease of $11.2M in the current position value, from $141M to 130M.

Below you can find more details about Garland Capital Management Inc portfolio as well as his latest detailed transactions.

Portfolio value $130 Million
Healthcare: $33.8 Million
Financial Services: $28.3 Million
Real Estate: $13.2 Million
Industrials: $12.5 Million
Consumer Defensive: $11.4 Million
Technology: $11 Million
Energy: $7.84 Million
Basic Materials: $4.09 Million
Other: $8 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 30
  • Current Value $130 Million
  • Prior Value $141 Million
  • Filing
  • Period Q3 2024
  • Filing Date October 30, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 27 stocks
Track This Portfolio

Track Garland Capital Management Inc Portfolio

Follow Garland Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garland Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Garland Capital Management Inc with notifications on news.